Pfizer CentreOne

Navigating the complexities of bringing your oral solid dose (OSD) product to market requires a strategic roadmap for success. From securing the specialized capabilities your product needs to scale production seamlessly, this journey presents challenges you must overcome. But what if you could make the complex simple? In our webinar, Pfizer's OSD experts detail how you can overcome these challenges with tips on: ?? Anticipating and mitigating risks throughout the development process ?? Harnessing scalable infrastructure and specialized expertise ? Proven strategies for simplifying your path to market Watch on-demand below ?? https://lnkd.in/eiu-SX_n #OralSolidDose #DrugManufacturing #CDMO

Today we celebrate International Men's Day, a day dedicated to recognizing the importance of men's health and wellbeing. This year's theme is about the impact of positive male role models on their families, friends, workplaces and communities. Across the Pfizer network, we value the diverse perspectives and talents of the men across our teams, and we are committed to fostering an inclusive environment where everyone feels supported and respected. Learn more about this important day and how you can get involved below ?? https://lnkd.in/gK7T3kK #InternationalMensDay

Join our Custom API and Biologics Senior Sales Manager, Justin Divan, as he discusses our large molecule capabilities and how we tackle the complex challenges of antibody therapeutics. In this Outsourced Pharma interview, hosted by Perry Rearick, in partnership with Life Science Connect, you can also expect to learn more about: ?? Our expertise in mAb therapies ?? Our specialized manufacturing site in Sanford, NC ?? How we leverage Pfizer's global network to bring innovative therapies to patients faster Watch now and learn how we're accelerating the journey of innovative therapies to patients: https://lnkd.in/e6Q37RCu #Biologics #Biopharma #DrugManufacturing #AntibodyTherapeutics

Your Antibody Drug Conjugate (ADC) therapy can transform patient lives. But bringing it to those who need it most can be a complicated journey. We're dedicated to helping you unravel these ADC complexities with bio-logic brilliance. Working closely with you at every stage of your project, we'll give you access to: ? 20+ years of ADC innovation ?? Cytotoxic compounds and drug substance intermediates ?? Specialized expertise in cytotoxic payloads, linkers and final ADC assembly Find out more about how a leading CDMO powered by Pfizer can accelerate your ADC for patients. ?? https://lnkd.in/eP-vZHvy #AntibodyDrugConjugates #Biologics #CDMO

Over the years monoclonal antibody therapies (mAbs) have opened up a new world of possibilities for biologics. ?? The potential these therapies continue to offer to treat life-altering diseases over the next decade continues to evolve, and we're excited to work with innovators at the forefront of it all. ?? As a leading CDMO powered by Pfizer, we recognize the life-saving opportunities that innovative antibody therapeutics like yours present, and we’re committed to helping you unlock its full potential. Find out how ?? https://lnkd.in/e-riva-j #mAbs #AntibodyTherapeutics #Antibodies #ADC

Antibody-drug conjugates (ADCs) are opening the door to new possibilities for cancer treatments. ?? But the complexities associated with bringing them to market presents unique challenges for drug developers. With intricate production processes and specific contained handling requirements to follow, specialized expertise and innovative solutions are essential to success. In our latest whitepaper, our Pfizer experts delve into the complexities of ADC development and manufacturing, offering valuable insights and strategies for overcoming these hurdles. Download below ?? https://lnkd.in/e6xDPA5W #AntibodyDrugConjugates #Biotech #DrugDevelopment

Today is the last chance for you to meet our team at BIO Europe. Pfizer's experts will be here until the end of the event to discuss your project and how our expertise and global capabilities can help propel it forward on its journey to patients. Join us to discuss how our: ??Regulatory expertise can help you navigate complex global and local market requirements ?? Deep go-to-market experience can help streamline your manufacturing processes and get your product to market ?? Robust security programs, digital and IP protection help safeguard your product ?? Scientific experts across 35+ global sites work together to support your oral solid dosage, sterile injectable and biologic needs. Left already? We're still available to talk. Learn more about us below ?? https://lnkd.in/dEZEwEyN #BIOEurope2024 #PharmaEvent #CDMO Ulrich Kaselow Claire Papadi Naz Cooper

The rise in demand for complex modalities such as gene and cell therapies (GCTs) and antibody drug conjugates (ADCs) has led to an increased demand for CDMOs that offer a full range of capabilities. ?? While pure-play CDMOs offer support across development to manufacturing, there is a distinct need for more specialized capabilities and capacity to meet demand for complex therapeutics. ?? That’s where integrated CDMOs come in. In our latest one-pager, we explore the benefits of working with an integrated CDMO and share how Pfizer CentreOne protects your project at every stage of the journey. Download now. ?? https://lnkd.in/eEXD9xRC #CDMO #DrugManufacturing #CGTs

Day one of Bio-Europe 2024 has begun, and we're here in Stockholm, Sweden for the next two days to meet with you and discuss your project's needs. Meet our Pfizer experts Ulrich Kaselow, Claire Papadi and Naz Cooper from November 4-6 to discover how our decades of pharmaceutical expertise, talented team and global manufacturing network can help you take the first step in your journey to market. Come and find us or arrange a booking below ?? https://lnkd.in/e5FHVgiY #BIOEurope2024 #PharmaEvent #CDMO

Complex modalities like gene and cell therapies (GCTs) and antibody drug conjugates (ADCs) are revolutionizing medicine, but their development and manufacturing come with unique challenges. While traditional plug-and-play CDMOs offer support, integrated CDMOs like Pfizer CentreOne can help provide distinct advantages, including: ?? Diverse teams and skill sets ?? Streamlined scale-up and tech transfers ?? Long-established supplier relationships ?? Listen to our latest podcast with Contract Pharma, where our Global Head of Strategic Account Management at Pfizer CentreOne Rick L. Knight, RPh, MBA, explores how integrated CDMOs are progressing therapies to patients waiting. .?? https://lnkd.in/eA88Y-CM #CDMO #CGTs #GeneTherapy